Cargando…
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatom...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543558/ https://www.ncbi.nlm.nih.gov/pubmed/28778178 http://dx.doi.org/10.1186/s13014-017-0859-z |
_version_ | 1783255167641059328 |
---|---|
author | Lyons, Ciara A. King, Raymond B. Osman, Sarah O.S. McMahon, Stephen J. O’Sullivan, Joe M. Hounsell, Alan R. Jain, Suneil McGarry, Conor K. |
author_facet | Lyons, Ciara A. King, Raymond B. Osman, Sarah O.S. McMahon, Stephen J. O’Sullivan, Joe M. Hounsell, Alan R. Jain, Suneil McGarry, Conor K. |
author_sort | Lyons, Ciara A. |
collection | PubMed |
description | BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatomical data. METHODS: Twenty patients with high-risk localized prostate cancer were selected for retrospective review. Individual volumes of interest (prostate, prostate and seminal vesicles and pelvic lymph nodes) were delineated on five representative CBCTs and registered to the planning CT using two registration protocols: bone match or prostate-based soft tissue match. Margins were incrementally expanded around composite CTV structures until 95% overlap was achieved. RESULTS: CTV-PTV margins of 5.2, 6.5 and 7.6 mm were required for prostate, prostate and seminal vesicles and pelvic lymph nodes respectively using a prostate matching protocol. For the prostate and seminal vesicle structures, margins calculated using our method displayed good agreement with a conventional margin recipe (within ±1.0 mm). CONCLUSIONS: We have presented an alternative method of CTV-PTV margin derivation that is applicable to SABR treatments with more than one isocentric target. These results have informed an institutional trial of prostate and pelvic nodal SABR in men with high-risk localized prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-017-0859-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5543558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55435582017-08-07 A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy Lyons, Ciara A. King, Raymond B. Osman, Sarah O.S. McMahon, Stephen J. O’Sullivan, Joe M. Hounsell, Alan R. Jain, Suneil McGarry, Conor K. Radiat Oncol Research BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatomical data. METHODS: Twenty patients with high-risk localized prostate cancer were selected for retrospective review. Individual volumes of interest (prostate, prostate and seminal vesicles and pelvic lymph nodes) were delineated on five representative CBCTs and registered to the planning CT using two registration protocols: bone match or prostate-based soft tissue match. Margins were incrementally expanded around composite CTV structures until 95% overlap was achieved. RESULTS: CTV-PTV margins of 5.2, 6.5 and 7.6 mm were required for prostate, prostate and seminal vesicles and pelvic lymph nodes respectively using a prostate matching protocol. For the prostate and seminal vesicle structures, margins calculated using our method displayed good agreement with a conventional margin recipe (within ±1.0 mm). CONCLUSIONS: We have presented an alternative method of CTV-PTV margin derivation that is applicable to SABR treatments with more than one isocentric target. These results have informed an institutional trial of prostate and pelvic nodal SABR in men with high-risk localized prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-017-0859-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-04 /pmc/articles/PMC5543558/ /pubmed/28778178 http://dx.doi.org/10.1186/s13014-017-0859-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lyons, Ciara A. King, Raymond B. Osman, Sarah O.S. McMahon, Stephen J. O’Sullivan, Joe M. Hounsell, Alan R. Jain, Suneil McGarry, Conor K. A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title | A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title_full | A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title_fullStr | A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title_full_unstemmed | A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title_short | A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
title_sort | novel cbct-based method for derivation of ctv-ptv margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543558/ https://www.ncbi.nlm.nih.gov/pubmed/28778178 http://dx.doi.org/10.1186/s13014-017-0859-z |
work_keys_str_mv | AT lyonsciaraa anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT kingraymondb anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT osmansarahos anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT mcmahonstephenj anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT osullivanjoem anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT hounsellalanr anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT jainsuneil anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT mcgarryconork anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT lyonsciaraa novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT kingraymondb novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT osmansarahos novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT mcmahonstephenj novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT osullivanjoem novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT hounsellalanr novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT jainsuneil novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy AT mcgarryconork novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy |